Literature DB >> 23376463

CMV promoter is repressed by p53 and activated by JNK pathway.

Marianna Rodova1, Renuka Jayini, Reddy Singasani, Elizabeth Chipps, M Rafiq Islam.   

Abstract

Viral promoters are widely utilized in commercial and customized vectors to drive expression of genes of interest including reporter, effector and transfection control, because of their high transcription efficiency in a variety of primary and transformed cell lines. However, we observed altered rate of transcription for these promoters under conditions such as presence of an effector protein. These variations in viral promoter driven expressions can potentially lead to incorrect conclusion, especially in comparative and quantitative experiments. We found significantly reduced viral promoter activity in cells overexpressing tumor suppressor protein p53, whereas markedly induced transcription in cells overexpressing MAP/ERK kinase kinase 1 (Mekk 1). Using deletion constructs generated from the CMV promoter, we found the transcription reduction by p53 is possibly mediated through the TATA motif present in proximal CMV promoter. The activation of the CMV promoter by Mekk 1, on the other hand, is attributed to the proximal CRE binding site in the promoter. These findings may be of interest to investigators who use CMV (or other viral) promoter driven vectors for either comparative or quantitative gene expression, or effect on promoter activity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376463      PMCID: PMC3650106          DOI: 10.1016/j.plasmid.2013.01.004

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  29 in total

1.  Transcriptional repression by p53 through direct binding to a novel DNA element.

Authors:  R A Johnson; T A Ince; K W Scotto
Journal:  J Biol Chem       Date:  2001-05-11       Impact factor: 5.157

Review 2.  AP-1 in cell proliferation and survival.

Authors:  E Shaulian; M Karin
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 3.  The ups and downs of MEK kinase interactions.

Authors:  C Hagemann; J L Blank
Journal:  Cell Signal       Date:  2001-12       Impact factor: 4.315

4.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

5.  p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas.

Authors:  Bhuvanesh Singh; Pabbathi G Reddy; Andy Goberdhan; Christine Walsh; Su Dao; Ivan Ngai; Ting Chao Chou; Pornchai O-Charoenrat; Arnold J Levine; Pulivarthi H Rao; Archontoula Stoffel
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

6.  Heterodimer formation between CREB and JUN proteins.

Authors:  D M Benbrook; N C Jones
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

7.  P53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex.

Authors:  Yubo Sun; Xiao-Rong Zeng; Leonor Wenger; Gary S Firestein; Herman S Cheung
Journal:  J Cell Biochem       Date:  2004-05-15       Impact factor: 4.429

8.  p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB.

Authors:  Diane Crighton; Annette Woiwode; Cheng Zhang; Nihar Mandavia; Jennifer P Morton; Lorna J Warnock; Jo Milner; Robert J White; Deborah L Johnson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

9.  Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.

Authors:  M R Montminy; L M Bilezikjian
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

10.  Wild-type p53 binds to the TATA-binding protein and represses transcription.

Authors:  E Seto; A Usheva; G P Zambetti; J Momand; N Horikoshi; R Weinmann; A J Levine; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

View more
  11 in total

1.  ATF5 regulates β-cell survival during stress.

Authors:  Christine A Juliana; Juxiang Yang; Andrea V Rozo; Austin Good; David N Groff; Shu-Zong Wang; Michael R Green; Doris A Stoffers
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

2.  Regulation of HFE expression by poly(ADP-ribose) polymerase-1 (PARP1) through an inverted repeat DNA sequence in the distal promoter.

Authors:  Christopher Pelham; Tamara Jimenez; Marianna Rodova; Angela Rudolph; Elizabeth Chipps; M Rafiq Islam
Journal:  Biochim Biophys Acta       Date:  2013-10-29

3.  APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites.

Authors:  Daniel Constantin; Gilles Dubuis; María Del Carmen Conde-Rubio; Christian Widmann
Journal:  FEBS J       Date:  2021-10-04       Impact factor: 5.622

4.  A Novel Interaction between TFII-I and Mdm2 with a Negative Effect on TFII-I Transcriptional Activity.

Authors:  Kateřina Cetkovská; Hana Šustová; Pavlína Kosztyu; Stjepan Uldrijan
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

5.  Cytosolic delivery of siRNA by ultra-high affinity dsRNA binding proteins.

Authors:  Nicole J Yang; Monique J Kauke; Fangdi Sun; Lucy F Yang; Katie F Maass; Michael W Traxlmayr; Yao Yu; Yingda Xu; Robert S Langer; Daniel G Anderson; K Dane Wittrup
Journal:  Nucleic Acids Res       Date:  2017-07-27       Impact factor: 16.971

6.  Development of a computational promoter with highly efficient expression in tumors.

Authors:  Shu-Yi Ho; Bo-Hau Chang; Chen-Han Chung; Yu-Ling Lin; Cheng-Hsun Chuang; Pei-Jung Hsieh; Wei-Chih Huang; Nu-Man Tsai; Sheng-Chieh Huang; Yen-Ku Liu; Yu-Chih Lo; Kuang-Wen Liao
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

7.  Mepazine Inhibits RANK-Induced Osteoclastogenesis Independent of Its MALT1 Inhibitory Function.

Authors:  Laura Meloni; Lynn Verstrepen; Marja Kreike; Jens Staal; Yasmine Driege; Inna S Afonina; Rudi Beyaert
Journal:  Molecules       Date:  2018-11-30       Impact factor: 4.411

8.  Using a Commonly Down-Regulated Cytomegalovirus (CMV) Promoter for High-Level Expression of Ectopic Gene in a Human B Lymphoma Cell Line.

Authors:  Xiaojun Yu; Wei Geng; Hongchuan Zhao; Guobin Wang; Yijun Zhao; Zhe Zhu; Xiaoping Geng
Journal:  Med Sci Monit       Date:  2017-12-15

Review 9.  Cyclophilin A as a target in the treatment of cytomegalovirus infections.

Authors:  Ashwaq A Abdullah; Rasedee Abdullah; Zeenathul A Nazariah; Krishnan N Balakrishnan; Faez Firdaus J Abdullah; Jamilu A Bala; Mohd-Azmi Mohd-Lila
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec

10.  MiR-23b-3p reduces the proliferation, migration and invasion of cervical cancer cell lines via the reduction of c-Met expression.

Authors:  Gabriela Elizabeth Campos-Viguri; Oscar Peralta-Zaragoza; Hilda Jiménez-Wences; Alma Edith Longinos-González; Carlos Alberto Castañón-Sánchez; Miriam Ramírez-Carrillo; César López Camarillo; Eduardo Castañeda-Saucedo; Marco Antonio Jiménez-López; Dinorah Nashely Martínez-Carrillo; Gloria Fernández-Tilapa
Journal:  Sci Rep       Date:  2020-02-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.